Cargando…

Long-term protection of hepatitis B vaccine in HIV-infected patients

Detalles Bibliográficos
Autores principales:	Biekre, R, Lasfar, N Ben, Viget, N, Valette, M, Baclet, V, Huleux, T, Senneville, E, Ajana, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220872/ http://dx.doi.org/10.1186/1471-2334-14-S2-O7

Ejemplares similares

Genetic determinants of hepatitis B vaccine response
por: Png, Eileen, et al.
Publicado: (2011)

High prevalence of asymptomatic HBV chronic carriage in HIV infected long term survivors
por: Temereanca, Aura, et al.
Publicado: (2014)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Hepatic cytolysis and Hepatitis E Virus infection in HIV-positive patients
por: Mazeron, Marie-Christine, et al.
Publicado: (2010)

OA06-05. Adaptation of HIV-1 to the human immune system at the population level is driven by protective HLA-B alleles
por: Schellens, IM, et al.
Publicado: (2009)

Any progress for HIV vaccines to come?
por: Wigzell, Hans
Publicado: (2006)

Misguiding cues used by HIV to thwart protective immunity
por: Reinherz, EL, et al.
Publicado: (2006)

Non-neutralizing antibodies and vaccine-induced protection
por: Demberg, Thorsten, et al.
Publicado: (2006)

Vaccine-elicited systemic and mucosal humoral responses of lactating rhesus monkeys vaccinated with the transmitted/founder HIV Envelope 1086C
por: Fouda, G, et al.
Publicado: (2012)

Elite control of HIV infection: implications for vaccines
por: Pereyra, Florencia, et al.
Publicado: (2006)

OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV
por: Tangy, F, et al.
Publicado: (2009)

Impact of the level of pre-ART CD4+ T cells in blood on the rectal HIV reservoir in long-term treated men (VIRECT study)
por: Vergnon-Miszczycha, Delphine, et al.
Publicado: (2014)

Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
por: Cevik, Muge, et al.
Publicado: (2012)

Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution in vivo
por: Pasternak, Alexander, et al.
Publicado: (2013)

Long-term post-trial follow-up of participants in randomised trials: lessons learned from the mrc / bhf heart protection study (HPS)
por: Aung, Theingi, et al.
Publicado: (2013)

OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial
por: de Souza, MS, et al.
Publicado: (2009)

Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors
por: Zhang, Mei-Yun, et al.
Publicado: (2006)

Four days a week and less on appropriate antiviral combinations provided long-term optimal control over HIV-1 in 92 patients
por: Leibowitch, Jacques, et al.
Publicado: (2014)

MDR Acinetobacter baumanni in the short term and long term acute care setting
por: Whitaker, JL
Publicado: (2011)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
por: Yokota, S, et al.
Publicado: (2008)

Long term outcome in children with shunted hydrocephalus
por: Mashhadinezhad, Hosein
Publicado: (2012)

Neuropathic pain: long term follow-up
por: Martin, Ernst, et al.
Publicado: (2015)

Support group for long term suffers of anorexia
por: Litchfield, Heather, et al.
Publicado: (2013)

Toward a glycopeptide-based HIV-1 vaccine
por: Wang, Lai-Xi, et al.
Publicado: (2006)

Improving the immunogenicity of HIV-1 envelope trimer vaccines
por: Sanders, Rogier W
Publicado: (2011)

Vaccination of HIV positive children... a genuine challenge
por: Vlad, Delia Adelina, et al.
Publicado: (2013)

Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2011)

Innate immune responses in acute HIV-1 infection: protective or pathogenic?
por: Borrow, Persephone, et al.
Publicado: (2013)

What do we learn from a Genome Wide Association Study performed on HIV-1 infected Long Term Non Progressors individuals?
por: Guergnon, Julien, et al.
Publicado: (2009)

Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
por: Horneff, G, et al.
Publicado: (2015)

S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
por: Inusa, B, et al.
Publicado: (2022)

Long-term methotrexate efficacy in juvenile localized scleroderma
por: Zulian, F, et al.
Publicado: (2011)

Long Term Mortality in Critically Ill Burn Survivors
por: Nitzschke, SL, et al.
Publicado: (2015)

Long-Term Follow-Up of Sepsis Induced Immunoparalysis
por: Raja, M, et al.
Publicado: (2015)

Dual acting antidepressants: what are the key aspects in terms of short and long term clinical efficacy?
por: Krüger, Stefanie
Publicado: (2007)

7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
por: Ruperto, N, et al.
Publicado: (2008)

S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania
por: Koehler, RN, et al.
Publicado: (2009)

Minimally invasive and surface electroporation delivery of DNA vaccines for the induction of robust humoral immune responses against HIV antigens
por: Sardesai, NY, et al.
Publicado: (2012)

S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY
por: Marktel, S, et al.
Publicado: (2022)

HIV-1 latency in activated T-cells
por: Berkhout, Ben
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_aj38faac29cpd6jqndlpuf2ums